Bristol-Myers Squibb Co. (BMY)
NYSE · Manufacturing · Pharmaceutical preparations
$62.86+$1.36 (+2.21%) on the dayAs of the close; data may be delayed.
BMY price, last 12 months
Key stats
- Previous close
- $61.50
- Open
- $61.75
- Day range
- $61.40 – $62.91
- 52-week range
- $42.52 – $68.64
- Volume
- 10.7M
- Avg volume (20 days)
- 10.6M
- Market cap
- $128.4B
Performance
1W−0.3%
1M−7.0%
3M+9.3%
6M+5.8%
YTD+16.5%
1Y+42.4%
vs S&P 500, 1Y+25.6 pts
Technicals and fundamentals
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $128.4B